Table 3 Time dependent analysis of all‐cause mortality, including both diabetes at baseline and new onset diabetes as a time dependent factor. CAD removed, paced rhythm added and CAD removed, AF added.
| RR (95% CI) | p Value | |
|---|---|---|
| Carvedilol v metoprolol | 0.792 (0.698 to 0.899) | 0.0003 | 
| Diabetes | 1.2 (1.046 to 1.377) | 0.0095 | 
| ↑ Age (per year) | 1.031 (1.023 to 1.038) | <0.0001 | 
| Female v male | 0.722 (0.603 to 0.863) | 0.0004 | 
| ↑ Weight (per kg) | 0.992 (0.987 to 0.997) | 0.0033 | 
| Systolic BP >120 mm Hg | 0.763 (0.667 to 0.873) | 0.0001 | 
| NYHA III v II | 1.429 (1.246 to 1.639) | <0.0001 | 
| NYHA IV v II | 1.722 (1.294 to 2.293) | 0.0002 | 
| ↑ Duration of HF (per month) | 1.001 (1 to 1.002) | 0.0044 | 
| ↑ LVEF (per%) | 0.976 (0.967 to 0.985) | <0.0001 | 
| Previous MI | 1.344 (1.167 to 1.548) | <0.0001 | 
| Stroke | 1.238 (0.997 to 1.538) | 0.0536 | 
| AF | 0.988 (0.835 to 1.169) | 0.8901 | 
| Digitalis | 1.45 (1.263 to 1.666) | <0.0001 | 
| Antiarrhythmic drugs | 1.556 (1.308 to 1.851) | <0.0001 | 
| Nitrates | 1.15 (1.003 to 1.318) | 0.0447 | 
| Lipid lowering | 0.767 (0.647 to 0.908) | 0.0021 | 
| ↑ Haemoglobin (g/l) | 0.924 (0.885 to 0.965) | 0.0003 | 
| ↑ Sodium (mmol/l) | 0.949 (0.933 to 0.965) | <0.0001 | 
| ↑ Creatinine (μmol/l) | 1.002 (1.001 to 1.003) | <0.0001 | 
CAD, coronary artery disease; AF, atrial fibrillation.